|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei C, Lai YQ, Li XX and Ye JX:
TGF-beta-activated kinase-1: a potential prognostic marker for
clear cell renal cell carcinoma. Asian Pac J Cancer Prev.
14:315–320. 2013. View Article : Google Scholar
|
|
3
|
Wu S, Lv Z, Wang Y, et al: Increased
expression of pregnancy up-regulated non-ubiquitous calmodulin
kinase is associated with poor prognosis in clear cell renal cell
carcinoma. PLoS One. 8:e599362013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Janzen NK, Kim HL, Figlin RA and
Belldegrun AS: Surveillance after radical or partial nephrectomy
for localized renal cell carcinoma and management of recurrent
disease. Urol Clin North Am. 30:843–852. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei C, Wu S, Li X, et al: High expression
of FER tyrosine kinase predicts poor prognosis in clear cell renal
cell carcinoma. Oncol Lett. 5:473–478. 2013.PubMed/NCBI
|
|
6
|
Yang XW, Zhang LJ, Huang XH, et al:
miR-145 suppresses cell invasion in hepatocellular carcinoma cells:
miR-145 targets ADAM17. Hepatol Res. 44:551–559. 2014. View Article : Google Scholar
|
|
7
|
Ha TY: MicroRNAs in human diseases: from
cancer to cardiovascular disease. Immune Netw. 11:135–154. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gottardo F, Liu CG, Ferracin M, et al:
Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou L, Chen J, Li Z, et al: Integrated
profiling of microRNAs and mRNAs: microRNAs located on Xq27.3
associate with clear cell renal cell carcinoma. PLoS One.
5:e152242010. View Article : Google Scholar
|
|
11
|
Wong TS, Liu XB, Wong BY, et al: Mature
miR-184 as potential oncogenic microRNA of squamous cell carcinoma
of tongue. Clin Cancer Res. 14:2588–2592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Foley NH, Bray IM, Tivnan A, et al:
MicroRNA-184 inhibits neuroblastoma cell survival through targeting
the serine/threonine kinase AKT2. Mol Cancer. 9:832010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhen Y, Liu Z, Yang H, et al: Tumor
suppressor PDCD4 modulates miR-184-mediated direct suppression of
C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal
carcinoma. Cell Death Dis. 4:e8722013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu GG, Li WH, He WG, et al: Mir-184
post-transcriptionally regulates SOX7 expression and promotes cell
proliferation in human hepatocellular carcinoma. PLoS One.
9:e887962014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leng HM, Qian WP, Zhou L, et al: Abnormal
expression and significance of MIR-184 in human renal carcinoma.
Beijing Da Xue Xue Bao. 43:509–513. 2011.(In Chinese). PubMed/NCBI
|
|
16
|
Lu R, Ji Z, Li X, et al: miR-145 functions
as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in
renal cell carcinoma. J Cancer Res Clin Oncol. 140:387–397. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ambros V: MicroRNA pathways in flies and
worms: growth, death, fat, stress, and timing. Cell. 113:673–676.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iorio MV, Ferracin M, Liu CG, et al:
MicroRNA gene expression deregulation in human breast cancer.
Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yanaihara N, Caplen N, Bowman E, et al:
Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wach S, Nolte E, Theil A, et al: MicroRNA
profiles classify papillary renal cell carcinoma subtypes. Br J
Cancer. 109:714–722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang A, Liu Y, Shen Y, Xu Y and Li X:
miR-21 modulates cell apoptosis by targeting multiple genes in
renal cell carcinoma. Urology. 78:474 e13–e19. 2011. View Article : Google Scholar
|
|
23
|
Li HY, Zhang Y, Cai JH and Bian HL:
MicroRNA-451 inhibits growth of human colorectal carcinoma cells
via downregulation of Pi3k/Akt pathway. Asian Pac J Cancer Prev.
14:3631–3634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang GK, Zhu JQ, Zhang JT, et al:
Circulating microRNA: a novel potential biomarker for early
diagnosis of acute myocardial infarction in humans. Eur Heart J.
31:659–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo LJ and Zhang QY: Decreased serum
miR-181a is a potential new tool for breast cancer screening. Int J
Mol Med. 30:680–686. 2012.PubMed/NCBI
|
|
26
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Walter BA, Valera VA, Pinto PA and Merino
MJ: Comprehensive microRNA Profiling of Prostate Cancer. J Cancer.
4:350–357. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu Z, Ni L, Chen D, et al: Identification
of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol.
44:669–677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim VN: MicroRNA biogenesis: coordinated
cropping and dicing. Nat Rev Mol Cell Biol. 6:376–385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yu XY, Zhang Z, Liu J, Zhan B and Kong CZ:
MicroRNA-141 is downregulated in human renal cell carcinoma and
regulates cell survival by targeting CDC25B. Onco Targets Ther.
6:349–354. 2013.PubMed/NCBI
|
